| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.006 |